Phreesia Securities Class Action Lawsuit
Analysis based on 61 articles · First reported Jun 15, 2026 · Last updated Jul 13, 2026
Phreesia's stock price dropped 26.6% following the revenue guidance cut, erasing significant market value. The lawsuit may lead to financial penalties and increased scrutiny of the company's disclosures, potentially affecting investor confidence and stock performance.
Multiple law firms have filed or announced a securities class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged violations of federal securities laws. The lawsuit claims that between May 8, 2025 and March 30, 2026, Phreesia made false and misleading statements regarding its pharmaceutical marketing commitments and revenue growth projections for fiscal year 2027. On March 30, 2026, Phreesia announced significantly lowered revenue growth projections, causing its stock price to fall 26.6% to $8.38 per share. The lead plaintiff deadline is July 13, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard